Ready 8-Ks
24
Latest filing
May 20, 2026, 4:44 PM ET
Top materiality
0.85
Event mix
earnings ×10 · other_material ×8 · other ×3
Sentiment
18 pos · 0 neg · 6 neu
Latest earnings
reported 2026-Q1
-
Curtiss-Wright enters new $1B revolving credit facility, replacing $750M facility
New $1 billion revolving credit facility (up from $750M) with five-year term maturing May 2031.
-
Curtiss-Wright shareholders elect all 10 director nominees, ratify auditor, approve say-on-pay
All 10 director nominees elected with votes ranging from 25.1M to 29.6M in favor.
-
Curtiss-Wright Q1 sales $914M (+13%), EPS $3.46; raises FY2026 guidance
Q1 sales $914M (+13% YoY), adjusted op margin 17.6% (+100bps), adjusted diluted EPS $3.48 (+23%).
-
Curtiss-Wright Q4 adj. EPS $3.79 (+16%), FY25 record sales $3.5B; FY26 EPS view $14.70-$15.15
Q4 sales $947M (+15%), adj. operating margin 19.7%, diluted EPS $3.69 (GAAP), adj. diluted EPS $3.79 (+16%).
-
Curtiss-Wright increases buyback authorization to $550M, declares $0.24 dividend
Board authorized additional $416M for share repurchases; total authorization now $550M.
-
Curtiss-Wright Q3 sales +9%, adj. EPS $3.40 +14%; raises FY2025 outlook
Q3 sales $869M (+9% YoY); adj. op. income $170M (+14%); adj. diluted EPS $3.40 (+14%).
-
Curtiss-Wright expands share repurchase by $200M, declares $0.24 quarterly dividend
Company adopts 10b5-1 plan to repurchase additional $200M, targeting record annual repurchases >$450M in 2025.
-
Curtiss-Wright expands 2025 share repurchase program by $200M, total now $266M
Adopted 10b5-1 trading plan to repurchase $200M of common stock; effective Aug 11, 2025, expected completion by end of August.
-
Curtiss-Wright Q2 2025: Sales up 12% to $877M; raises FY2025 guidance
Q2 reported sales $877M (+12% YoY), operating income $156M (+21%), diluted EPS $3.19 (+24%).
-
Curtiss-Wright boosts buyback authorization by $400M and raises dividend 14% to $0.24/share
Board authorized additional $400M in share repurchases, total authorization now $534M.
-
Curtiss-Wright Q1 EPS $2.68 beats; raises FY25 guidance (sales +8-9%, EPS $12.45-12.80)
Q1 sales $806M (+13% YoY); diluted EPS $2.68 (+35%); adjusted EPS $2.82 (+42%).
-
Curtiss-Wright annual meeting results: all director nominees elected, auditor ratified, say-on-pay approved
All 10 director nominees elected with substantial majorities; highest vote 29.8M for Anthony Moraco, lowest 26.4M for Peter Wallace.
-
Curtiss-Wright reports record FY2024 sales of $3.1B, issues 2025 guidance for double-digit EPS growth
Q4 sales $824M (+5%), adj. EPS $3.27 (+3%); FY sales $3.1B (+10%), adj. EPS $10.90 (+16%).
-
Curtiss-Wright expands 2024 share repurchase by $100M, raises 2025 annual plan to $60M
New $100M 10b5-1 share repurchase program to be executed by Dec 31, 2024, bringing total 2024 buybacks to $250M.
-
Curtiss-Wright adopts 10b5-1 trading plans for share repurchases up to $160M in 2025
First plan: $60M repurchases executed equally over calendar year 2025, effective Jan 2–Dec 31, 2025.
-
Curtiss-Wright GC Paul Ferdenzi retires; George McDonald named successor
Paul Ferdenzi retiring after 25 years; steps down as GC and Corp Sec effective Nov 13, 2024.
-
Curtiss-Wright Q3 sales $799M (+10%), adj EPS $2.97 (+17%); raises FY guidance
Sales $799M (+10%), adj operating income $149M (+11%), adj operating margin 18.7% (+20 bps).
-
Curtiss-Wright expands 2024 share repurchase by $100M to $150M, declares $0.21 dividend
$100M expansion of 2024 share repurchase program; total expected repurchases now $150M in 2024.
-
Curtiss-Wright Q2 adj. EPS $2.67 (+24% YoY); raises full-year 2024 guidance
Q2 sales $785M (+11% YoY); adj. op. margin 17.0% (+60 bps); adj. diluted EPS $2.67 (+24%).
-
Curtiss-Wright introduces 3-year targets: >5% organic revenue CAGR, >10% EPS CAGR
Organic revenue CAGR of at least 5% over 2024-2026, with EPS CAGR exceeding 10%.
-
Curtiss-Wright boosts buyback authorization by $300M and raises dividend 5% to $0.21
Board authorized $300M share repurchase increase, total available authorization now $400M.
-
Curtiss-Wright stockholders elect directors and approve proposals at 2024 annual meeting
All 10 director nominees elected; Peter C. Wallace received lowest support at 82.4% for.
-
Curtiss-Wright Q1 sales up 13% to $713M, EPS $1.99; raises full-year guidance
Q1 sales $713M (+13% YoY), operating income $100M (+27%), diluted EPS $1.99 (+30%).
-
Curtiss-Wright reports record FY23 sales $2.8B, adj EPS $9.38; guides FY24 EPS $10-10.30
Q4 adj diluted EPS $3.16 (+8% YoY); Q4 sales $786M (+4%) on 3% organic growth.